Cancer vaccine (Coley/GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCancer vaccine (Coley/GlaxoSmithKline)
Drug Alias NameVaxImmune - Coley/GlaxoSmithKline
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsLung NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia